TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: maximal rate of torque development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: voluntary activation (100‐Hz doublet stimulation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quadriceps twitch amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritability score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Moderate/severe exacerbation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PTSD treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: Levels of IL‐1β, TNF‐α, and IL‐6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median time to primary outcome
Endpoint domain: Mortality/survival
Primary endpoint: Rate of rotator cuff retears
Endpoint domain: Adverse events/effects
Primary endpoint: Osteointegration at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: PENN scores at 2 years
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: dyspnea intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: wound-healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cavity volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to SARS-CoV-2 clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cecal abundance of Porphyromonadaceae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cecal abundance of Barnesiella
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cecal abundance of unclassified Ruminococcaceae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IG count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IG percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-peptide retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: percent predicted diffusing capacity of the lung for carbon monoxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intention to adhere to low-risk drinking guidelines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lumen diameter increase at distal RVS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative decrease in salivary cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of KA TKAs achieving optimal balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: technical quality of care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: care team interpersonal manner
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 24-h systolic blood pressure (SBP) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: glucose concentration at 120 min OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: School trajectory disruption
Endpoint domain: Life impact
Endpoint subdomain: Educational outcomes
Primary endpoint: Grade ≥2 Oral Mucositis (OM)
Endpoint domain: Adverse events/effects
Primary endpoint: Intraclass correlation coefficient (ICC) for agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mechanosensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in central corneal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in scotopic CDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence (AUC96‐264, Cmax96‐264, Cmin96‐264)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patch adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential metabolites associated with PM2.5 exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: self-care score
Endpoint domain: Life impact
Endpoint subdomain: Self-care
Primary endpoint: Peripheral oxygen saturation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delirium rate within the first month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of ITU stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Combustible cigarette smoking reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days alive and out of hospital at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Discontinuation of glucose-lowering medication treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of lung involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: knowledge about PST
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: attitude towards PST
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-efficacy regarding PST
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: V̇o2peak improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dinnertime intake of red and orange vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily dietary intake of fruit and fruit juice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Activity Score in 28 joints with C reactive protein <3.2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in maternal and child nutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consent intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consent subjective norms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consent attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: stiffness outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: knowledge gain in drug treatment and physical therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved average GaCS scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ESAS relief
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Fewer grade ≥3 leukopenia
Endpoint domain: Adverse events/effects
Primary endpoint: occupational performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first analgesic request
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: self-reported sleep efficiency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: actigraphy-measured sleep duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ∆MIP%predicted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ∆MLHFQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maturity rate of arteriovenous fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visuomotor speed improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive flexibility improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: multitasking performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tooth retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated salt intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acceptability of salt substitute
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to salt substitute
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with IGA score of 0 or 1 with improvement by at least two grades at week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: poststenotic CT-FFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with adverse events per 100 patient‐years
Endpoint domain: Adverse events/effects
Primary endpoint: Combined rod-cone a-wave amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of treatment for plantar fasciitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linkage rates to PrEP/ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cytoreductive outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: rate of grade 3-5 complications
Endpoint domain: Adverse events/effects
Primary endpoint: MACE incidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CV mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Pain VAS during local anesthetic infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain
Primary endpoint: Pain VAS during intra-articular injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pain
Primary endpoint: Skeletal muscle mass index (SMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: glucagon levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: norepinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: epinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative incidence of oral mucositis (OM) grade 1-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reoccurring drug-like experiences
Endpoint domain: Adverse events/effects
Primary endpoint: Pain freedom at 2 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of the most bothersome migraine‐associated symptom at 2 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events within 48 h
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in FPE-related concerns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in social anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of good prognosis
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of post-surgery complications
Endpoint domain: Adverse events/effects
Primary endpoint: Intraventricular hemorrhage clearance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance of Active Surveillance (AS)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Postprandial glucose area under the curve (AUC) 70-150 mins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Coronal malalignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sagittal malalignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of deep infection
Endpoint domain: Adverse events/effects
Primary endpoint: percentage of normal recovery graded by I-FEED scoring
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: subscores of life ability and physical well-being at post-operative 72 h
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: strength of hand grip post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean healthcare OOPE per infant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: risk of impoverishment due to healthcare seeking
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Decrease in anti-dsDNA antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median time to clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: surgical quality assessed as leak pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: haemorrhagic transition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: complete clearance of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Implant Bone Level (IBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-year distant recurrence-free interval (DRFI)
Endpoint domain: Mortality/survival
Primary endpoint: Management of opioid-induced constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: increase in gross and fine motor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual‐motor integration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pancreatic fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean respiratory rate (RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: association with mortality
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of women with labor exceeding 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median survival time after metastasis
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative survival rates at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: IV success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttesting confidence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MAP-MCAv coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAP-MCAv phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAP-MCAv gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission at week 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS scores for local infusion site discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy improvements of tofacitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss to Follow-Up (LTFU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first documentation of LTFU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress (GHQ-28)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total effective rate in the treatment of gastrointestinal reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average hospitalization length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total cholesterol improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Triglycerides improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Depression status improvement (HDRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional parameters improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Traumatic Childbirth Perceptions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: no shortness of breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: lowest risk of asthma flare-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Long-term outcome from ICH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of BUN and Scr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Complete wart clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand grip strength improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA decline ≥30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CI-AKI prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Retention in care and adherence to ART
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Foley catheter removal on postoperative day two
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: biochemically confirmed quitting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in cigarettes smoked per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median operation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Long-term cardiovascular mortality
Endpoint domain: Mortality/survival
Primary endpoint: Concentration of TNF‐α in PICF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Ground Reaction Force (GRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Perceived participation
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: 30-day rate of death or RRT
Endpoint domain: Mortality/survival
Primary endpoint: 30-day rate of death
Endpoint domain: Mortality/survival
Primary endpoint: 30-day rate of RRT
Endpoint domain: Mortality/survival
Primary endpoint: Area under the curve (AUC) for predicting TMB-H CRC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BBPS score in the right colon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: elevation of serum creatinine
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in AS symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days of ICU and hospital stays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for cervical dilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Complications during dilatation
Endpoint domain: Adverse events/effects
Primary endpoint: WOMAC pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement in KSS score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Improvement in SDS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Wound closure > 90%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Genetic variability of T. cruzi bloodstream populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of survival at 27 years
Endpoint domain: Mortality/survival
Primary endpoint: Patient-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: LSM total effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: APRI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: FIB-4 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: modified Rankin scale score of 0 to 3 at 90 days
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: improvement of at least 8 points on the NIHSS score at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: any intracranial hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Change in balance (CBM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mobility (s-CBM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good visibility of the upper‐middle pharynx
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall technical difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharyngeal bleeding rate
Endpoint domain: Adverse events/effects